PRELUDE CAPITAL MANAGEMENT, LLC - EXAGEN INC ownership

EXAGEN INC's ticker is XGN and the CUSIP is 30068X103. A total of 36 filers reported holding EXAGEN INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of EXAGEN INC
ValueSharesWeighting
Q3 2020$1,000
-80.0%
117
-71.9%
0.00%
Q2 2020$5,000
-28.6%
4170.0%0.00%
Q1 2020$7,000
+40.0%
417
+108.5%
0.00%
Q4 2019$5,0002000.00%
Other shareholders
EXAGEN INC shareholders Q4 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,037,074$2,520,0900.84%
PERKINS CAPITAL MANAGEMENT INC 259,905$6320.60%
COWEN AND COMPANY, LLC 943,552$2,292,8310.27%
Penbrook Management LLC 74,010$179,8440.14%
RTW INVESTMENTS, LP 1,391,184$3,380,5770.07%
Nantahala Capital Management 132,613$322,2500.02%
WASATCH ADVISORS LP 1,000,561$2,431,3630.02%
First Bank & Trust 16,793$40,8070.01%
SILVERCREST ASSET MANAGEMENT GROUP LLC 502,615$1,221,3540.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 47,300$114,9390.00%
View complete list of EXAGEN INC shareholders